Takeda Pharmaceutical Company Limited Profit Loss Before Tax
Takeda Pharmaceutical Company Limited (TAK) reported Profit Loss Before Tax of JPY 175.08 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2025-06-25
| Period end | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|
| 2025-03-31 | 175.08B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 52.79B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 375.09B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 302.57B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 366.24B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | -60.75B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 127.61B JPY 20-F · filed 2021-06-29 | 94.90B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 217.21B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 143.35B JPY 20-F · filed 2019-06-27 |